H Lenk
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations, Immune Response and Inflammation, Chemotherapy-induced cardiotoxicity and mitigation, Computational Drug Discovery Methods
Most-Cited Works
- → Phase II clinical trial of high-dose recombinant human tumor necrosis factor(1989)62 cited
- Mitoxantrone: mechanism of action, antitumor activity, pharmacokinetics, efficacy in the treatment of solid tumors and lymphomas, and toxicity.(1988)
- A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.(1992)
- Human pharmacological investigation of a human recombinant tumor necrosis factor preparation (PAC-4D) a phase-I trial.(1988)
- → Human Pharmacological Investigation of a Human Recombinant Tumor Necrosis Factor Preparation(2015)6 cited
- → Phase II Study of Pirarubicin (THP-Adriamycin) in Metastatic Breast Cancer Patients(1990)6 cited
- [Mitoguazone (methylglyoxal bis(guanylhydrazone))--its status and prospects].(1989)
- → Pretherapeutic in Vitro Prediction of Human Tumour Drug Response(1984)
- → Book Reviews(1990)
- [Results of antineoplastic chemotherapy based on the oncobiogram].(1989)